The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curnock, A. P.
Right arrow Articles by Ward, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curnock, A. P.
Right arrow Articles by Ward, S. G.
The Journal of Immunology, 2003, 170: 4021-4030.
Copyright © 2003 by The American Association of Immunologists

Optimal Chemotactic Responses of Leukemic T Cells to Stromal Cell-Derived Factor-1 Requires the Activation of Both Class IA and IB Phosphoinositide 3-Kinases1

Adam P. Curnock2, Yannis Sotsios2, Karen L. Wright and Stephen G. Ward3

Department of Pharmacy and Pharmacology, Bath University, Bath, United Kingdom

Stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 are a multifunctional chemokine/receptor system with essential roles in the development of the immune system and other aspects of embryogenesis, including vascularization and organ development. SDF-1 is also a potent chemoattractant for T cells and has roles in both inflammation and immune homeostasis. Our group has previously demonstrated that phosphoinositide 3-kinase (PI 3-kinase) is activated in SDF-1-stimulated T cells and is indeed required for SDF-1-mediated chemotaxis. In this study Jurkat clones were established, stably expressing dominant negative constructs of class IA and class IB PI 3-kinases under the control of the tetracycline off inducible gene system, to determine the relative roles of these PI 3-kinases in SDF-1 signaling. Our results show that expression of either kinase-dead PI3K{gamma} (KD-PI3K{gamma}) or {Delta}p85 (a construct unable to bind class IA p110{alpha}, -{beta}, or -{delta}) leads to a partial inhibition of SDF-1-stimulated protein kinase B phosphorylation, but had no effect on SDF-1-induced phosphorylation of the mitogen-activated protein kinase ERK1/2. Functional studies demonstrated that expression of KD-PI3K{gamma} markedly inhibited SDF-1-mediated chemotaxis, typically eliciting 40–60% inhibition. Interestingly, the expression of {Delta}p85 also leads to inhibition of the SDF-1-mediated chemotactic response, albeit to a much lesser extent than achieved with the KD-PI3K{gamma} mutant, typically in the range of 20–40% inhibition. Furthermore, the inhibition of chemotaxis by the expression of dominant negative class IA or class IB PI 3-kinases could be enhanced by the presence of the PI 3-kinase inhibitor LY294002. Together, these results demonstrate that optimal chemotactic response of leukemic T cells to SDF-1 requires the activation of both class IA and class IB PI 3-kinases.




This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
S. Chen, F. Lin, M. E. Shin, F. Wang, L. Shen, and H. E. Hamm
RACK1 Regulates Directional Cell Migration by Acting on G{beta}{gamma} at the Interface with Its Effectors PLC{beta} and PI3K{gamma}
Mol. Biol. Cell, September 1, 2008; 19(9): 3909 - 3922.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. T. Murooka, R. Rahbar, L. C. Platanias, and E. N. Fish
CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1
Blood, May 15, 2008; 111(10): 4892 - 4901.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Pinho, R. de Castro Russo, F. A. Amaral, L. P. de Sousa, M. M. Barsante, D. G. de Souza, J. C. Alves-Filho, D. C. Cara, J. S. Hayflick, C. Rommel, et al.
Tissue- and Stimulus-Dependent Role of Phosphatidylinositol 3-Kinase Isoforms for Neutrophil Recruitment Induced by Chemoattractants In Vivo
J. Immunol., December 1, 2007; 179(11): 7891 - 7898.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Matheu, J. A. Deane, I. Parker, D. A. Fruman, and M. D. Cahalan
Class IA Phosphoinositide 3-Kinase Modulates Basal Lymphocyte Motility in the Lymph Node
J. Immunol., August 15, 2007; 179(4): 2261 - 2269.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Tan, D. Martin, and J. S. Gutkind
The G{alpha}13-Rho Signaling Axis Is Required for SDF-1-induced Migration through CXCR4
J. Biol. Chem., December 22, 2006; 281(51): 39542 - 39549.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Z. Zeng, I. J. Samudio, M. Munsell, J. An, Z. Huang, E. Estey, M. Andreeff, and M. Konopleva
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
Mol. Cancer Ther., December 1, 2006; 5(12): 3113 - 3121.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. G. Cronshaw, A. Kouroumalis, R. Parry, A. Webb, Z. Brown, and S. G. Ward
Evidence that phospholipase C-dependent, calcium-independent mechanisms are required for directional migration of T lymphocytes in response to the CCR4 ligands CCL17 and CCL22
J. Leukoc. Biol., June 1, 2006; 79(6): 1369 - 1380.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Akekawatchai, J. D. Holland, M. Kochetkova, J. C. Wallace, and S. R. McColl
Transactivation of CXCR4 by the Insulin-like Growth Factor-1 Receptor (IGF-1R) in Human MDA-MB-231 Breast Cancer Epithelial Cells
J. Biol. Chem., December 2, 2005; 280(48): 39701 - 39708.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Kouroumalis, R. J. Nibbs, H. Aptel, K. L. Wright, G. Kolios, and S. G. Ward
The Chemokines CXCL9, CXCL10, and CXCL11 Differentially Stimulate G{alpha}i-Independent Signaling and Actin Responses in Human Intestinal Myofibroblasts
J. Immunol., October 15, 2005; 175(8): 5403 - 5411.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Gao, R. L. Wange, N. Zhang, J. J. Oppenheim, and O. M. Z. Howard
Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN
Blood, October 15, 2005; 106(8): 2619 - 2626.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Fukuda, H. E. Broxmeyer, and L. M. Pelus
Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1{alpha}(CXCL12)/CXCR4 axis
Blood, April 15, 2005; 105(8): 3117 - 3126.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Kryczek, A. Lange, P. Mottram, X. Alvarez, P. Cheng, M. Hogan, L. Moons, S. Wei, L. Zou, V. Machelon, et al.
CXCL12 and Vascular Endothelial Growth Factor Synergistically Induce Neoangiogenesis in Human Ovarian Cancers
Cancer Res., January 15, 2005; 65(2): 465 - 472.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Reif, K. Okkenhaug, T. Sasaki, J. M. Penninger, B. Vanhaesebroeck, and J. G. Cyster
Cutting Edge: Differential Roles for Phosphoinositide 3-Kinases, p110{gamma} and p110{delta}, in Lymphocyte Chemotaxis and Homing
J. Immunol., August 15, 2004; 173(4): 2236 - 2240.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
G. M. Fuhler, K. A. Cadwallader, G. J. Knol, E. R. Chilvers, A. L. Drayer, and E. Vellenga
Disturbed granulocyte macrophage-colony stimulating factor priming of phosphatidylinositol 3,4,5-trisphosphate accumulation and Rac activation in fMLP-stimulated neutrophils from patients with myelodysplasia
J. Leukoc. Biol., July 1, 2004; 76(1): 254 - 262.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. G. Cronshaw, C. Owen, Z. Brown, and S. G. Ward
Activation of Phosphoinositide 3-Kinases by the CCR4 Ligand Macrophage-Derived Chemokine Is a Dispensable Signal for T Lymphocyte Chemotaxis
J. Immunol., June 15, 2004; 172(12): 7761 - 7770.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
B.-C. Lee, T.-H. Lee, S. Avraham, and H. K. Avraham
Involvement of the Chemokine Receptor CXCR4 and Its Ligand Stromal Cell-Derived Factor 1{alpha} in Breast Cancer Cell Migration Through Human Brain Microvascular Endothelial Cells
Mol. Cancer Res., June 1, 2004; 2(6): 327 - 338.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
C. Gomez-Mouton, R. A. Lacalle, E. Mira, S. Jimenez-Baranda, D. F. Barber, A. C. Carrera, C. Martinez-A., and S. Manes
Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis
J. Cell Biol., March 1, 2004; 164(5): 759 - 768.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. J. Brown, R. Nijhara, J. A. Hallam, M. Gignac, K. M. Yamada, S. L. Erlandsen, J. Delon, M. Kruhlak, and S. Shaw
Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization
Blood, December 1, 2003; 102(12): 3890 - 3899.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.